Cellectar Biosciences, Inc. (CLRB)

Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $25.73 million. The enterprise value is $18.28 million.

Market Cap	25.73M
Enterprise Value	18.28M

Important Dates

The last earnings date was Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

CLRB has 7.99 million shares outstanding. The number of shares has increased by 141.46% in one year.

Current Share Class	7.99M
Shares Outstanding	7.99M
Shares Change (YoY)	+141.46%
Shares Change (QoQ)	+3.20%
Owned by Insiders (%)	2.06%
Owned by Institutions (%)	7.36%
Float	7.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.73
P/TBV Ratio	8.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.32.

Current Ratio	1.90
Quick Ratio	1.71
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -290.42% and return on invested capital (ROIC) is -170.99%.

Return on Equity (ROE)	-290.42%
Return on Assets (ROA)	-102.96%
Return on Invested Capital (ROIC)	-170.99%
Return on Capital Employed (ROCE)	-358.20%
Weighted Average Cost of Capital (WACC)	6.23%
Revenue Per Employee	n/a
Profits Per Employee	-$1.89M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.03% in the last 52 weeks. The beta is 0.43, so CLRB's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-57.03%
50-Day Moving Average	2.93
200-Day Moving Average	3.63
Relative Strength Index (RSI)	58.07
Average Volume (20 Days)	3,053,549

Short Selling Information

The latest short interest is 22,951, so 0.29% of the outstanding shares have been sold short.

Short Interest	22,951
Short Previous Month	27,204
Short % of Shares Out	0.29%
Short % of Float	0.29%
Short Ratio (days to cover)	0.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.37M
Pretax Income	-20.84M
Net Income	-20.84M
EBITDA	-22.16M
EBIT	-22.37M
Earnings Per Share (EPS)	-$6.35

Balance Sheet

The company has $8.35 million in cash and $1.53 million in debt, with a net cash position of $6.82 million or $0.85 per share.

Cash & Cash Equivalents	8.35M
Total Debt	1.53M
Net Cash	6.82M
Net Cash Per Share	$0.85
Equity (Book Value)	4.72M
Book Value Per Share	0.66
Working Capital	4.39M

Cash Flow

In the last 12 months, operating cash flow was -$18.58 million and capital expenditures -$9,258, giving a free cash flow of -$18.59 million.

Operating Cash Flow	-18.58M
Capital Expenditures	-9,258
Depreciation & Amortization	210,701
Net Borrowing	n/a
Free Cash Flow	-18.59M
FCF Per Share	-$2.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-141.46%
Shareholder Yield	-141.46%
Earnings Yield	-83.05%
FCF Yield	-74.08%

Analyst Forecast

The average price target for CLRB is $10.33, which is 220.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.33
Price Target Difference	220.81%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 24, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date	Jun 24, 2025
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	1